BNET Industries
St. Jude Medical Inc. (STJ) is in the Health Care Industry
- Revenue
- Dec 29 2007
- $3.7B
- Profit
- Dec 29 2007
- $559.0M
- Market Cap
- Oct 09 2008
- $11.8B
Latest News and Analysis
Revisions Ratios Help Uncover Hidden Gems
Zacks.com submits: Our Director of Zacks Equity Research Dirk van Dijk, CFA slices and dices all sorts of data on publicly traded industries. Recently, we got his take on something called a “revisions ratio,” and managed to get a few Buy recommendations in the process. You track...
IHI: Medical Devices Make a Momentum Comeback
Don Dion submits: In the last few months of tough stock-market sledding, one of the tried-and-true axioms of investing has come to the forefront: The health care sector is a good place to hide during bear markets. Over the last three months (through Aug. 8), seven funds...
St. Jude Medical: Safety in a Wild Market
Joshua Hayes submits: In a market where investing can be very dangerous, there are very few options to go to where one can be safe. Well, just like being in some horrible accident, in the stock market you can always find relief in medical stocks. Obviously, some stand out compared...
St. Jude Medical, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer SessionThank you. [Operator Instructions]. Your first question is from Bob Hopkins [ph] with Banc of America. Please go ahead. Unidentified Analyst Thanks [ph] and good morning and congrats on the results. Daniel J. Starks - Chairman, President and Chief Executive Officer Good morning Bob. Unidentified Analyst I have...
St. Jude Medical Announces CE Mark Approval and European Launch of TigerWire Steerable Guidewire
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE: STJ) today announced European CE Mark approval and the European launch of the TigerWire[TM] Steerable Guidewire. The announcement was made in Barcelona, Spain, at EuroPCR 2008, a premiere scientific and professional event for cardiologists, vascular surgeons and other medical specialists who...
Research and Markets: Analysis of St. Jude Medical, Inc. Provides a Comprehensive Insight into This Company
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c92582) has announced the addition of "Analysis of St. Jude Medical, Inc." to their offering.
St. Jude Medical Announces Launch of New Circular Mapping Catheter
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the U.S. launch of the Reflexion Spiral X[TM] variable radius mapping catheter at Heart Rhythm 2008. This new catheter will provide physicians with greater maneuverability, stability and control when used in the left atrium for the mapping of abnormal...
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Clinical trial will investigate effectiveness of implantable cardioverter defibrillator therapy in heart attack patients
St. Jude Medical Announces the Release of EnSite System Version 8.0 Software
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced the release of its EnSite[TM] System Version 8.0 software. The new software will help physicians more intuitively visualize the anatomy of the heart to diagnose and treat abnormal heart rhythms. St. Jude Medical will feature the EnSite v.8.0 at...
St. Jude Medical Announces FDA Approval of Next-Generation Remote Monitoring and Data Management System for Implantable Cardiac Devices
Merlin.net Patient Care Network contacts patients with automated interactive voice response system
St. Jude Medical to Launch New Brand Identity
The new brand identity will combine the company's commitment to meeting customer needs with its reputation for quality
St. Jude Medical Announces FDA Clearance and CE Mark Approval of Strada Carotid Guiding Sheath
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration FDA clearance and European CE Mark approval of the Strada[TM] Carotid Guiding Sheath, a flexible tube through which physicians can deliver balloon catheters, stents and other tools to open blockages in the carotid arteries....
St. Jude Medical Announces U.S. Launch of TigerWire Steerable Guidewire
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. launch of the TigerWire[TM] Steerable Guidewire. The newest member of the St. Jude Medical GuideRight[TM] family of steerable guidewires, the TigerWire Steerable Guidewire is designed to enhance physicians' ability to steer through challenging peripheral arteries, the vessels that...
St. Jude Medical Awarded U.S. Patent for Neurostimulation Therapy for Depression
Brodmann Area 25 Study Moves Forward With Enrollment of First Patient
St. Jude Medical Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer SessionThank you. [Operator Instructions] Your first question is from Mike Weinstein from JPMorgan. Please go ahead. Mike Weinstein - JPMorgan Good morning and thank you for taking the question. Dan, I was hoping you could give us first a feel for what's playing out in the CRM markets....
St. Jude Medical Reports First Quarter Results
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the first quarter ended March 29, 2008.
St. Jude Medical Receives FDA and CE Mark Approvals for the World's Smallest, Longest-Lasting Rechargeable Neurostimulator to Treat Chronic Pain
Eon Mini Combines Greater Patient Comfort With 10-Year Battery Longevity
St. Jude Medical Announces First Quarter 2008 Earnings Conference Call
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) will hold its quarterly conference call to discuss First Quarter 2008 results on Wednesday, April 16th at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). A news release will be issued at 8:00 a.m. Eastern Time (7:00 a.m. Central Time).
St. Jude Medical Announces Japanese Approval of the Merlin Programmer for Pacemakers, ICDs and CRT Devices
New programmer will provide quick and easy device programming
St. Jude Medical Announces Japanese Approval and Launch of Tailor Flexible Ring and Band for Heart Valve Repair
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval from the Ministry of Health, Labor and Welfare MHLW, in addition to reimbursement approval, of the SJM Tailor[R] Flexible Ring and SJM Tailor[R] Flexible Band, the company's first products in Japan for repairing diseased heart valves.
- Next »
- page 1 of 19
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- FDA (27 results)
- Patient (14 results)
- health care (13 results)
- agreement (12 results)
- software (9 results)
- Company (9 results)
- stock (8 results)
- S&P 500 (8 results)
- Microsoft Windows CE (7 results)
- clinical trial (7 results)
- board of directors (6 results)
- therapy (6 results)
- (5 results)
- shareholder (5 results)
- physician (5 results)
- medical device (4 results)
- EPIC (4 results)
- board (4 results)
- Boston Scientific Corp. (4 results)
- Epicor Software Corp. (4 results)
- acquisition (4 results)
- sales (4 results)
- CRM (3 results)
- IDE (3 results)
- Medtronic Inc. (3 results)
- class action (3 results)
- Bear Stearns & Co. Inc. (3 results)
- Atlas (3 results)
- tool (3 results)
- Incorporated: 1976
- CEO: Mr. Daniel J. Starks
St. Jude Medical is engaged in the development, manufacturing and distribution of cardiovascular medical devices for the cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. Co.'s four operating segments are Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Advanced Neuromodulation Systems. Co markets and sells its products through both a direct sales force and independent distributors. The principal geographic markets for Co.'s products are the U.S., Europe, Japan and Asia Pacific.
Key Competitors
St. Jude Medical Inc. Company Info
Board of Directors
Mr. Daniel J. Starks
Chairman
Mr. Richard R. Devenuti
Dr. Stuart M. Essig Ph.D.
Mr. Thomas H. Garrett III
Ms. Wendy L. Yarno
Mr. John W. Brown
Mr. Barbara B. Hill
Mr. Michael A. Rocca
Mr. Stephan K. Widensohler
Contact Information
One Lillehei Plaza
St. Paul, MN
1 651 483-2000
NAICS Code
Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
